Technical Analysis for WAVE - Waverly Pharma Inc.

Grade Last Price % Change Price Change
F 0.015 0.00% 0.000
WAVE closed up 50.0 percent on Wednesday, November 6, 2024, on 22 percent of normal volume.
Earnings due: Nov 25
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 50.00%
Reversal New Lows Setup Bearish Swing Setup 50.00%
Volume Surge Other 50.00%
Wide Bands Range Expansion 50.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.00%

   Recent Intraday Alerts

Alert Time
Gapped Up (Full) 2 days ago
Up 1 ATR 2 days ago
Up 5% 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Waverley Pharma Inc is a Canada-based company engaged in Biotechnology & Medical Research sector.The Company is focused on developing and commercializing Safe and Effective Small Molecules for Treatment of Cancer. Waverley Pharma is working in collaboration with a Indian conglomerate based in Mumbai to develop products for the treatment of cancer. Two of the lead products under developments are: WAV-101: WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications; WAV-102 is also an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. The Company has signed an agreement with Omgene Life Sciences for the development of another generic anti-cancer product WAV-103.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Occupational Safety And Health Medicine Pharma Labor Drug Biotechnology Science Cancer Life Sciences Therapy Collaboration Oncology Drug Development Lung Cancer Treatment Of Cancer Chemotherapy Non Small Cell Lung Cancer Multiple Myeloma Treatment Of Non Small Cell Lung Cancer

Is WAVE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.135
52 Week Low 0.01
Average Volume 22,908
200-Day Moving Average 0.048
50-Day Moving Average 0.021
20-Day Moving Average 0.016
10-Day Moving Average 0.016
Average True Range 0.005
RSI (14) 46.81
ADX 7.66
+DI 22.673
-DI 31.081
Chandelier Exit (Long, 3 ATRs) 0.011
Chandelier Exit (Short, 3 ATRs) 0.024
Upper Bollinger Bands 0.023
Lower Bollinger Band 0.009
Percent B (%b) 0.41
BandWidth 85.890
MACD Line -0.002
MACD Signal Line -0.002
MACD Histogram -0.0003
Fundamentals Value
Market Cap 810 Thousand
Num Shares 54 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -0.94
Price-to-Sales 6.91
Price-to-Book 3.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.015
Resistance 3 (R3) 0.015 0.015 0.015
Resistance 2 (R2) 0.015 0.015 0.015 0.015
Resistance 1 (R1) 0.015 0.015 0.015 0.015 0.015
Pivot Point 0.015 0.015 0.015 0.015 0.015
Support 1 (S1) 0.015 0.015 0.015 0.015 0.015
Support 2 (S2) 0.015 0.015 0.015 0.015
Support 3 (S3) 0.015 0.015 0.015
Support 4 (S4) 0.015